Hironobu Saito

Corporate Officer / Head of Medical Affairs Division, Daiichi Sankyo Co., Ltd. Japan

He became team leader of anti-hypertensive agents in Japan from 1997 to 2005. From 2006, he also had the responsibility for Asian development section and became senior vice director to register in the rest of world. From 2012, he became vice president of new drug regulatory affairs Department in Japan. He became vice president of oncology clinical development in Japan from 2016 April.On 2020 April , he became Corporate Officer, Head of Medical Affairs Division. He had been Chairman of DIA Asian Workshop in Japan for 5 years. He got DIA outstanding award in 2007. From 2019 June, He will be Chair of DIA advisory Committee of Japan. He has been JPMA rep. of ICH steering Committee in JPMA from 2012 to 2016.
  • Hiroyuki Aono

    Senior Advisor, Research and Development Solutions Center of Excellence, IQVIA Services Japan K.K.

  • Toru Fujieda

    President, CMIC Co., Ltd.

  • Katsuhiko Ichimaru

    Director of MID-NET Operation and Management, Pharmaceuticals and Medical Devices Agency (PMDA)

  • Akiko Ikeda

    Senior Manager, Policy Intelligence Dept., Integrated Market Access Division, Janssen Pharmaceutical K.K.

  • Junichi Imagawa

    Department Manager, Drug Safety Coordination Department, Drug Safety Division, Chugai Pharmaceutical Co., Ltd.

  • Yoichi Ishikawa

    Professor, Department of Pediatric Medication, Meiji Pharmaceutical University

  • Hideki Maeda

    Professor, Department of Regulatory Science, Meiji Pharmaceutical University

  • Noriko Morishita

    Manager, Clinical Trial Promotion Office, National Hospital Organization Headquarters

  • Harumasa Nakamura

    Director of Clinical Research Support Office, Translational Medical Center, National Center of Neurology and Psychiatry

  • Junichi Nishino

    Director, Medical Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd.

  • Satoshi Saeki

    Senior Director, Japan-Asia Clinical Development 2, Astellas Pharma Inc.

  • Takuko Sawada

    Director of the Board, Executive Vice President, Shionogi & Co., Ltd.

  • Shuji Sumida

    Senior Specialist, Business Strategy & Compliance Department, Chugai Pharmaceutical Co., Ltd.

  • Kozo Takase

    Professor, Department of Medical Informatics, Tokyo Medical and Dental University (TMDU)

  • Hideo Tomiya

    Executive Director, Educational Activities for Pharmaceutical Professionals, Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ)

  • Takayuki Yoshino

    Department of Gaestrointestinal Oncology, National Cancer Center Hospital East